Table 9.
Year | Ti–Cu alloy | Animal model | In vivo results | [Ref.] |
---|---|---|---|---|
2009 | Ti–1Cu Ti–5Cu (No machining and treatment process) |
Japanese white rabbits | 1) Ti-1% Cu alloy significantly inhibited inflammation and infection. 2) The osteoid formations on Ti-1% Cu alloy was excellent as well as pure titanium, but was diminished in Ti-5% Cu alloy. 3) The postoperative blood copper level was not significantly different from preoperative. |
[17] |
2015 | Ti–10Cu (Powder metallurgy) | New Zealand white rabbits | Ti–10Cu alloy had as good bone biocompatibility as cp-Ti, which brought no toxicity to the surrounding cell and tissue and no delayed to bone healing. | [251] |
2018 | Ti–5Cu (850 °C/2 h/furnace cooling | Beagles | Ti–Cu implant not only effectively reduced the bone resorption but also stimulated the new bone formation compared to Ti. | [255] |
2019 | Ti–10Cu (Powder metallurgy) | New Zealand white rabbits | Ti–Cu alloy exhibited strong in vivo antibacterial properties while serious infection, inflammation and fester were observed in the cp-Ti. | [195] |